Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer-Reference-Cited by-同舟云学术

Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer

Published:2016-03-22 Issue:17 Volume:7 Page:24677-24687
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hyun Kyung-A¹,Koo Gi-Bang²³,Han Hyunju⁴,Sohn Joohyuk⁵,Choi Wonshik⁶,Kim Seung-Il⁷,Jung Hyo-Il¹,Kim You-Sun²³

Affiliation:

1. School of Mechanical Engineering, Yonsei University, Seoul, Korea

2. Department of Biochemistry, Ajou University School of Medicine, Suwon, Korea

3. Department of Biomedical Sciences, Graduate School, Ajou University, Suwon, Korea

4. Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea

5. Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea

6. Department of Physics, Korea University, Seoul, Korea

7. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages;Analytical Chemistry;2024-08-02

2. Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution;Cancer Cell International;2024-06-27

3. Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes;2024-06-17

4. Hypericin-mediated photodynamic therapy inhibits metastasis and EMT of colorectal cancer cells by regulating RhoA–ROCK1 signaling pathway;Photochemical & Photobiological Sciences;2024-06-12

5. STIM1, ORAI1, and KDM2B in circulating tumor cells (CTCs) isolated from prostate cancer patients;Frontiers in Cell and Developmental Biology;2024-06-05